BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 31121314)

  • 21. Ankle arthritis predicts polyarticular disease course and unfavourable outcome in children with juvenile idiopathic arthritis.
    Esbjörnsson AC; Aalto K; Broström EW; Fasth A; Herlin T; Nielsen S; Nordal E; Peltoniemi S; Rygg M; Zak M; Berntson L;
    Clin Exp Rheumatol; 2015; 33(5):751-7. PubMed ID: 26213158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescribing for Children With Rheumatic Disease: Perceived Treatment Approaches Between Pediatric and Adult Rheumatologists.
    van Mater H; Balevic SJ; Freed GL; Clark SJ
    Arthritis Care Res (Hoboken); 2018 Feb; 70(2):268-274. PubMed ID: 28464558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Juvenile arthritis management in less resourced countries (JAMLess): consensus recommendations from the Cradle of Humankind.
    Scott C; Chan M; Slamang W; Okong'o L; Petty R; Laxer RM; Katsicas MM; Fredrick F; Chipeta J; Faller G; Pileggi G; Saad-Magalhaes C; Wouters C; Foster HE; Kubchandani R; Ruperto N; Russo R
    Clin Rheumatol; 2019 Feb; 38(2):563-575. PubMed ID: 30267356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk Factors and Biomarkers for the Occurrence of Uveitis in Juvenile Idiopathic Arthritis: Data From the Inception Cohort of Newly Diagnosed Patients With Juvenile Idiopathic Arthritis Study.
    Tappeiner C; Klotsche J; Sengler C; Niewerth M; Liedmann I; Walscheid K; Lavric M; Foell D; Minden K; Heiligenhaus A
    Arthritis Rheumatol; 2018 Oct; 70(10):1685-1694. PubMed ID: 29732713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the time of patients' admission to the tertiary pediatric rheumatology center for juvenile idiopathic arthritis.
    Kurt T; Tekin ZE; Çelikel E; Aydın F; Tekgöz N; Sezer M; Karagöl C; Coşkun S; Kaplan MM; Öner N; Polat MC; Sezer S; Acar B
    ARP Rheumatol; 2022; 1(4):286-292. PubMed ID: 36617311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends in prescription of biological agents and outcomes of juvenile idiopathic arthritis: results of the Dutch national Arthritis and Biologics in Children Register.
    Otten MH; Anink J; Prince FH; Twilt M; Vastert SJ; ten Cate R; Hoppenreijs EP; Armbrust W; Gorter SL; van Pelt PA; Kamphuis SS; Dolman KM; Swart JF; van den Berg JM; Koopman-Keemink Y; van Rossum MA; Wulffraat NM; van Suijlekom-Smit LW
    Ann Rheum Dis; 2015 Jul; 74(7):1379-86. PubMed ID: 24641940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Later-onset rheumatoid factor negative polyarticular juvenile idiopathic arthritis (JIA): a unique patient group?
    Greenwald AG; Zakerzadeh A; Laxer RM; Schneider R; Cameron B; Feldman B; Spiegel L; Tse SM; Silverman ED
    Clin Exp Rheumatol; 2013; 31(4):645-52. PubMed ID: 23622111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Antiinflammatory Treatment on the Onset of Uveitis in Juvenile Idiopathic Arthritis: Longitudinal Analysis From a Nationwide Pediatric Rheumatology Database.
    Tappeiner C; Schenck S; Niewerth M; Heiligenhaus A; Minden K; Klotsche J
    Arthritis Care Res (Hoboken); 2016 Jan; 68(1):46-54. PubMed ID: 26212111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in paediatric rheumatology referral times and disease activity indices over a ten-year period among children and young people with Juvenile Idiopathic Arthritis: results from the childhood arthritis prospective Study.
    McErlane F; Foster HE; Carrasco R; Baildam EM; Chieng SE; Davidson JE; Ioannou Y; Wedderburn LR; Thomson W; Hyrich KL
    Rheumatology (Oxford); 2016 Jul; 55(7):1225-34. PubMed ID: 27016664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors associated with a longer time to access pediatric rheumatologists in Canadian children with juvenile idiopathic arthritis.
    Shiff NJ; Tucker LB; Guzman J; Oen K; Yeung RS; Duffy CM
    J Rheumatol; 2010 Nov; 37(11):2415-21. PubMed ID: 20716664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testing population-based performance measures identifies gaps in juvenile idiopathic arthritis (JIA) care.
    Barber CEH; Lix LM; Lacaille D; Marshall DA; Kroeker K; Benseler S; Twilt M; Schmeling H; Barnabe C; Hazlewood GS; Bykerk V; Homik J; Thorne JC; Burt J; Mosher D; Katz S; Shiff NJ
    BMC Health Serv Res; 2019 Aug; 19(1):572. PubMed ID: 31412858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Juvenile idiopathic arthritis managed in the new millennium: one year outcomes of an inception cohort of Australian children.
    Tiller G; Buckle J; Allen R; Munro J; Gowdie P; Cox A; Akikusa J
    Pediatr Rheumatol Online J; 2018 Nov; 16(1):69. PubMed ID: 30413164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 'Snakes & Ladders': factors influencing access to appropriate care for children and young people with suspected juvenile idiopathic arthritis - a qualitative study.
    Rapley T; May C; Smith N; Foster HE
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):43. PubMed ID: 33757545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pre-Rheumatology Referral Consultation and Investigation Pattern in Children with Joint Complaints: Focus on Juvenile Idiopathic Arthritis.
    Marino A; Baldassarre P; Ferrigno C; Biuso A; Minutoli M; Baldo F; Costi S; Gattinara MV; Caporali RF; Chighizola CB
    Children (Basel); 2024 May; 11(5):. PubMed ID: 38790595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Knee pain as a reason for referral to a paediatric rheumatologist: A retrospective study.
    Gorczyca D; Iwańczyk P; Staś K; Postępski J
    J Paediatr Child Health; 2023 Mar; 59(3):439-444. PubMed ID: 36627832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric Rheumatology Care and Outcomes Improvement Network's Quality Measure Set to Improve Care of Children With Juvenile Idiopathic Arthritis.
    Bingham CA; Harris JG; Qiu T; Gilbert M; Vora SS; Yildirim-Toruner C; Ferraro K; Lovell DJ; Taylor J; Mannion ML; Weiss JE; Laxer RM; Shishov M; Oberle EJ; Gottlieb BS; Lee TC; Pan N; Burnham JM; Fair DC; Batthish M; Hazen MM; Spencer CH; Morgan EM;
    Arthritis Care Res (Hoboken); 2023 Dec; 75(12):2442-2452. PubMed ID: 37308458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What matters most for patients, parents, and clinicians in the course of juvenile idiopathic arthritis? A qualitative study.
    Guzman J; Gómez-Ramírez O; Jurencak R; Shiff NJ; Berard RA; Duffy CM; Oen K; Petty RE; Benseler SM; Brant R; Tucker LB
    J Rheumatol; 2014 Nov; 41(11):2260-9. PubMed ID: 25225279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Features and Clinical Course of Infantile Juvenile Idiopathic Arthritis.
    Campbell JA; Shenoi S
    J Clin Rheumatol; 2022 Mar; 28(2):e609-e611. PubMed ID: 33843769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical profile and juvenile arthritis damage index in children with juvenile idiopathic arthritis: A study from a tertiary care center in south India.
    Menon NVB; Peethambaran G; Puthiyapurayil AT; Nambudakath C; Arakkal R
    Int J Rheum Dis; 2018 Apr; 21(4):871-879. PubMed ID: 27309679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance.
    Horton DB; Onel KB; Beukelman T; Ringold S
    J Rheumatol; 2017 Mar; 44(3):352-360. PubMed ID: 28148696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.